Back
ProShares UltraShort MSCI Emerging Markets Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
29
EEV
ProShares UltraShort MSCI Emerging Markets
Last Price:
$14.34
Seasonality Move:
-0.29%
Sell
42
RGC
Regencell Bioscience Holdings
Last Price:
$699.12
Seasonality Move:
1.42%
Sell
29
ProShares UltraShort MSCI Emerging Markets (EEV)
is a Sell
Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?
-
The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $13.64. The Score for EEV is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
EEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $624.95. The Score for RGC is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EEV Stock Price Chart
What is ProShares UltraShort MSCI Emerging Markets's stock price today?
-
The ProShares UltraShort MSCI Emerging Markets share price today is $13.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EEV is experiencing slight selling pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $624.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.
EEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 34.93 | Sell |
Chaikin Money Flow: | 14855 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 137.86 | Buy |
Relative Strength Index (14 RSI): | 60.94 | Buy |
Chaikin Money Flow: | -665 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
EEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.01 | Sell |
20-day SMA: | 14.05 | Sell |
50-day SMA: | 15.41 | Sell |
200-day SMA: | 16.12 | Sell |
8-day EMA: | 13.95 | Sell |
20-day EMA: | 14.15 | Sell |
50-day EMA: | 13.08 | Buy |
200-day EMA: | 6.36 | Buy |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 656.47 | Sell |
20-day SMA: | 498.4 | Buy |
50-day SMA: | 226.51 | Buy |
200-day SMA: | 61.97 | Buy |
8-day EMA: | 627.72 | Sell |
20-day EMA: | 502.5 | Buy |
50-day EMA: | 310.16 | Buy |
200-day EMA: | 106.81 | Buy |
ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort MSCI Emerging Markets Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |